Multicenter clinical study on the biapenem treatment for bacterial infection in intensive care unit

Jing WANG,Xin RAO,Bo HU,Jianguo LI

DOI: https://doi.org/10.3969/j.issn.1006-2483.2018.01.026

2018-01-01

Abstract:Objective To evaluate the efficacy and the safety of biapenem in the treatment of bacterial infection in intensive care unit ( ICU) . Methods This study was a retrospective multicenter research. The 805 patients who were suspected bacterial infection from 17 ICUs in China were received biapenem during Janary1 to October 1 in 2013. The inclusion criterion was adults patients who were highly suspected bacterial infection and in the treatment of biapenem more than three days in ICU. The clinical efficacy, bacterial eradication rates and drug-related adverse reactions were evaluated. Results After the treatment of biapenem,the effective rate was 85. 19％(650/763),and the experimental inflectional index,the severity of illness,the functions of organs,the fever clearance time,the length of the mechanical ventilation and ICU stays all improved. The bacterial clearance rate was 84. 17％(452/537). According to the drug susceptibility,neither the drug sensibility nor resistance of biapenem were inferior than imipenem and meropenem. The rate of adverse drug reaction was only 1. 06％. The adverse reactions were the rash or itchy skin,nausea and vomiting and the case numbers were respectively eight,seven and three. Conclusion Biapenem was satisfactory in the treatment of bacterial infection in ICU in view of the clinical efficacy,bacterial clearance and safety.